p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas

American Journal of Hematology
K B B PagnanoS T Saad

Abstract

The expression of p53, p21/WAF-1, Mdm2, c-Myc, and proliferating cell nuclear antigen (PCNA) proteins was examined by the immunohistochemistry of paraffin-embedded tissues of 62 patients with aggressive non-Hodgkin's lymphomas (NHL) and correlated to clinical data. Expression of p53, p21/WAF-1, Mdm2, and c-Myc protein was observed in 17 out of 62 cases (30%), 25 out of 60 (42%), 13 out of 44 (30%), and 39 out of 51 (76.5%), respectively. The p53+/p21WAF-1 phenotype, which is more frequently found in p53 mutations, was associated with a worse overall survival (P = 0.04) and with a lower rate of complete response (CR) (PF = 0.01). p53 and c-Myc negative expression was related to a better response to chemotherapy (PF = 0.005 and 0.035, respectively). The expression of p53, c-Myc, and Mdm2 was related to a shortened overall survival (P < 0.001, 0.05, and 0.037, respectively), suggesting that the expression of these proteins could be associated with a poor outcome in these patients.

References

Oct 1, 1992·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M Oren
Nov 22, 1991·Science·R A Weinberg
Jun 6, 1991·Nature·A J LevineC A Finlay
Apr 1, 1981·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S M HsuH Fanger
Jan 1, 1994·Journal of Clinical Pathology·P KorkolopoulouJ Crocker
Nov 25, 1994·Science·J Marx
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Dec 10, 1993·Science·J Marx
Mar 1, 1994·International Journal of Cancer. Journal International Du Cancer·V De ReM Boiocchi
Mar 1, 1996·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·N KawamataJ W Said
May 1, 1997·American Journal of Hematology·B Martinez-DelgadoJ Benitez
May 15, 1997·Nature·Y HauptM Oren
May 15, 1997·Nature·M H KubbutatK H Vousden
Aug 21, 1997·The New England Journal of Medicine·A IchikawaT Hotta
May 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E SanchezM A Piris
Jun 25, 1998·Leukemia & Lymphoma·S NavaratnamJ B Johnston
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·T KamijoC J Sherr
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·W Tao, A J Levine
Oct 29, 1999·Genes & Development·C M EischenJ L Cleveland

❮ Previous
Next ❯

Citations

Jun 17, 2005·Journal of Physiology and Biochemistry·M el-FarH el-Baz
Jun 2, 2005·Cancer Letters·Andrew SlackJason M Shohet
Jan 18, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Francisca I CamachoMiguel A Piris
Mar 17, 2006·Applied Immunohistochemistry & Molecular Morphology : AIMM·Paola ChabayMaria Victoria Preciado
Aug 31, 2010·The Journal of Pharmacology and Experimental Therapeutics·Dana M ClausenJulie L Eiseman
Jan 15, 2005·Blood·Irene M GhobrialThomas E Witzig
Feb 10, 2006·Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine·H WuM Inoue
Oct 24, 2002·Blood·Margarita Sánchez-BeatoMiguel A Piris
Aug 29, 2017·Expert Opinion on Investigational Drugs·Christian KleinGünter Fingerle-Rowson
Dec 27, 2016·Frontiers in Pharmacology·Stefania TrinoPellegrino Musto
Jun 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kofi AsomaningGeoffrey Liu
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhuo ZhangRuiwen Zhang
Apr 2, 2002·Biochemical and Biophysical Research Communications·Seiji FukudaLouis M Pelus

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.